Clinical Research Directory
Browse clinical research sites, groups, and studies.
Laparoscopic Versus Robot-assisted Left-sided Pancreatectomy for Benign and Pre-malignant Lesions (DIPLOMA-3)
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Summary
The DIPLOMA-3 trial is an international, multicenter, patient-blinded randomized controlled trial comparing laparoscopic and robot-assisted left-sided pancreatectomy. Patients with an indication for elective left-sided pancreatecomy for benign or premalignant lesions in the body or tail of the pancreas and considered eligible will be randomized between laparoscopic and robot-assisted resection.
Official title: Laparoscopic Versus Robot-assisted Left-sided Pancreatectomy for Benign and Pre-malignant Lesions (DIPLOMA-3): an International Multicenter Patient-blinded Randomized Controlled Trial
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
256
Start Date
2025-06-01
Completion Date
2028-06-01
Last Updated
2025-09-04
Healthy Volunteers
No
Conditions
Interventions
Laparoscopic minimally invasive left-sided pancreatecomy
Laparoscopic minimally invasive left-sided pancreatecomy
Robot-assisted minimally invasive left-sided pancreatecomy
Robot-assisted minimally invasive left-sided pancreatecomy
Locations (1)
Amsterdam UMC
Amsterdam, Netherlands